Skip to content

Sybil J. Fisher, DPM

NPI 1558338848ActiveIndividual· Podiatrist· Houston, TX

Podiatrist (DPM) in Houston, Texas, trained at New York College of Podiatric Medicine (class of 2001). 311 Medicare patients in 2024, $225,123 paid; nearly all of their 351 Part D prescriptions were generic (98%). Anika Therapeutics, Inc. was the largest of 5 companies reporting payments in 2025, $323.87 in all, mostly food and beverage.

Overview

NPI1558338848
StatusActive
Entity typeIndividual
CredentialDPM
Sole proprietorNo
NPI issuedMar 5, 2006
Last updated in NPPESOct 14, 2018

Specialties and licenses

TaxonomyCodeLicenseState
Podiatrist Primary213E00000X1609TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Podiatry (TX)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients311
Services billed1,515 across 48 procedure codes
Paid by Medicare$225,123

Part D prescriptions in 2024

Prescriptions (claims)351 · 450 30-day fills
Patients147
Total drug cost$27,044
Generic share98% of claims

Medicare sources and data years

Education and affiliations

Medical schoolNew York College of Podiatric Medicine
Graduation year2001
Medicare specialtyPodiatry

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$323.87 · 9 payments from 5 companies
  • 2024$344.18 · 12 payments from 3 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$323.87 · 9 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other podiatrists in Houston

All 150 podiatrists in Houston · All podiatrists in Texas